What Are Good Stocks to Invest In Right Now?

TradingKey - Investors like to think that timing the bottom of the stock market is extremely difficult. An expert may get it wrong – as evidenced by many recent mistakes made by professional investors.

Success as an investor requires a focus on buying shares of high-quality companies with strong fundamentals, competitive advantages, and a solid potential for future growth, no matter what the size of your investment ($1k through $50k).

One thing you should remember when you are choosing an investment is to pick good quality businesses that will be able to survive and prosper through different economic climates.

The current market includes many options ranging from tech companies doing innovative work around AI, to the healthcare industry revolutionising medicine, to consumer businesses benefiting from demographic changes. 

Many substantial companies have numerous opportunities for investment. There are many of today’s biggest companies focused on developing the next generation of exciting technology and/or business models.

Here are some of the best stocks to purchase (in terms of stock price, growth potential, and financial strength) that will provide a great source of income in the future.

Amazon

Amazon (AMZN) currently accounts for 40% of all E-commerce sales and is the largest seller in the United States. It is also the largest provider of Cloud Computing to date, with Amazon Web Services representing approximately 30% of all Cloud Sales.

Amazon is also venturing into new business segments such as Digital Advertising, Grocery Delivery, Logistics, and Artificial Intelligence (AI).

AI significantly impacts all business processes for Amazon, from package delivery to advertisement strategy to supply chain management, using advanced technology to improve customer experience and ultimately create new forms of revenue.

Currently, Amazon's AI DeepFleet employs nearly one million robots to provide effective and cost-efficient autonomous delivery by utilizing aerial drone delivery solutions.

Financially, both operating margins are improving, and Amazon continues to deliver earnings and a positive Forward P/E Ratio of approximately 33. Therefore, Amazon is providing good returns based on expected future growth. Consequently, Amazon is poised to be one of the most attractive investment opportunities available due to its position in both AI and E-commerce.

Alphabet

Technological advances have been one of the major factors driving Alphabet's (GOOGL) growth opportunities, and as such Alphabet continues to incorporate AI into its operations across all areas.

Approximately 650 million people worldwide will use Alphabet's Gemini AI platform monthly as part of its efforts to continue monetizing through search engine results, page views, and advertisers on the YouTube website; thus, it is the largest digital ad agency worldwide.

Alphabet's revenue for the third quarter was $102.35 billion, beating analysts' predictions of $99.85 billion.

When removing traffic acquisition costs (exTAC), Alphabet's revenue reached $87.47 billion, exceeding analyst expectations of $85.11 billion.

Net income for the quarter surged 41% year over year to $28.5 billion, with earnings per share (EPS) reaching $2.87 — significantly beating Wall Street estimates of $2.26.

At a forward P/E of approximately 33, Alphabet remains reasonably priced given how the company has evolved with respect to deep integration of AI into its current products and $98.5 billion in cash on its balance sheet, thus making it one of the best stocks to buy today for long-term investors.

Eli Lilly

Eli Lilly (LLY) is the top player in the rapidly growing GLP-1 (glucagon-like peptide-1) market, which is expected to reach over $100 billion by 2030. Both Mounjaro (used for diabetes management) and Zepbound (for weight loss) are dual-acting medications that have taken share in the marketplace because of their effectiveness.

In addition to its current portfolio of products, Eli Lilly is developing multiple new products. In addition to the previously announced retatrutide and orforglipron, which are oral medications used for weight management and diabetes control that have demonstrated favorable preliminary clinical trial data, the firm is developing other new drugs.

Eli Lilly's growth has been remarkable and reached $17.6 billion in sales for the third quarter of Fiscal Year 2025 — an increase of 54% from Q3 FY 2024. Eli Lilly is also continuing its longstanding commitment to achieving total customer satisfaction by investing heavily in its manufacturing and supply-chain operations with new and/or improved facilities.

In addition, Eli Lilly has demonstrated its commitment to returning value to its shareholders with an annual increase of at least 15% in dividends over the last 7 years.

AbbVie

One of a handful of Dividend Kings, having raised dividends for 50 years or longer, AbbVie (ABBV) delivers a solid income stream while also having a great pipeline of innovation. 

AbbVie disclosed its Third Quarter (Q3) 2025 results, reporting Total Revenue of $44.542 Billion (+8.0%) for the first three quarters of 2025, with Q3 reporting a Total Revenue of $15.776 Billion (+9.1%). 

The large majority of AbbVie's growth in Q3 was due to the impressive performance of AbbVie's two major autoimmune drug franchises, which are both classified as blockbusters. AbbVie's immunology drug franchise is truly the cornerstone of AbbVie’s growth. 

The IL-23 mab Skyrizi (Lysinib) and the JAK1 Inhibitor Rinvoq (Upatinib) demonstrated strong double-digit percentage increases.

AbbVie will continue to grow as a result of its acquisitions as well as its pipeline of products. As an example, AbbVie bought bretisilocin, which shows good potential for the treatment of depression, and ISB 2001, which engages T-cells in treating multiple myeloma. AbbVie has approximately 90 clinical programs in the pipeline, including both neuroscience and oncology programs based on psychedelics.

Walmart

Walmart (WMT), an enormous retailer, has shown real strength during tough economic times by staying strong while many competitors have gone out of business. 

As the largest retail chain worldwide, Walmart's superior size permits it to deliver lower-priced items than almost all its competitors. Therefore, Walmart is able to attract a wide range of customers from high-income earners to low-income earners.

In addition, because of its combination of brick-and-mortar as well as an outstanding website, together with its top-notch customer service, Walmart has helped itself to grow much quicker than other e-commerce companies.

Additionally, Walmart is diversifying its revenue sources into more profitable venues, such as advertising and memberships (e.g., Walmart+ and Sam's Club are both experiencing double-digit growth). 

Total revenue for the third quarter of 2025 was $179.5 billion, representing a 6% year over year growth. 

Dutch Bros and e.l.f. Beauty

If you are an investor in the consumer growth sector, watch both Dutch Bros (BROS) and e.l.f. Beauty (ELF). Dutch Bros has accelerated its growth plan to double its number of locations to more than 2000 by the year 2029; one way to achieve this is by testing new hot food offerings that have the potential to spur 4 percent-plus same-store sales growth.

Through acquiring the new skincare brand Rhode, which has gained a lot of attention recently with its substantial social media audience, e.l.f. will be able to introduce many new lines of products as well as many new channels of distribution of these products with flooring partners such as Sephora and Ulta.

How to Choose the Best Stock to Buy Right Now

Whether investing in stocks today or doing other things, you should check the company's fundamentals (comparable companies, how the company can continue to generate profits on a long-term basis, and the company's underlying financial strength) before investing in its stocks.

Long-term sustainable advantages over its competitors, solid balance sheet, and growth opportunities due to macro/economic and technology developments.